Skip to main content

Table 1 Excreted nucleoside concentrations of the strains used in this work

From: Increased production of inosine and guanosine by means of metabolic engineering of the purine pathway in Ashbya gossypii

Strain

Genotype

Parental strain

Inosine (mg/L)

Guanosine (mg/L)

A4

Wild type

-

11.1 ± 2.4

75.3 ± 4.2

A5

Wild type

-

6.3 ± 2.3

53.3 ± 5.1

A6

Wild type

-

6.0 ± 4.2

64.1 ± 8.2

A7

Wild type

-

11.4 ± 1.3

33.4 ± 2.7

A8

Wild type

-

5.4 ± 1.0

15.3 ± 4.2

A9

Wild type

-

2.8 ± 1.1

81.7 ± 7.1

A10

Wild type

-

6.6 ± 2.3

77.8 ± 4.1

I0

* GPD:ADE4 des

A4

12.5 ± 2.0

77.2 ± 6.1

I1

GPD:ADE4 des , ΔADE12

I0

144.1 ± 7.3

92.8 ± 8.5

I2

GPD:ADE4 des , ΔADE12, ΔIMD3

I1

227.9 ± 9.1

70.9 ± 6.2

I3

GPD:ADE4 des , ΔADE12, ΔIMD3, GPD:IMD3

I2

44.51 ± 6.3

137.1 ± 3.4

I4

GPD:ADE4 des , ΔADE12, ΔPNP1

I1

268.8 ± 8.1

138.0 ± 6.9

I5

GPD:ADE4 des , ΔADE12, GPD:ISN1

I1

145.2 ± 5.1

92.2 ± 7.1

I6

GPD:ADE4 des , ΔADE12, ΔIMD3, ΔPNP

I4

76.3 ± 4.8

27.1 ± 4.3

I7

GPD:ADE4 des , ΔADE12, GPD:GUA1

I1

143.7 ± 6.2

91.3 ± 4.5

I8

GPD:ADE4 des , ΔADE12, RIB7p:RIB1

I1

136.4 ± 8.2

100.0 ± 4.1

  1. *This strain has been described previously in [17].